Pharmacy Practice and Science Department Highlights: April 2019

(April 10, 2019)

Publications

Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study. BMC Nephrology 2019 20:81.

Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in solid tumours versus haematological malignancies: patterns, outcomes, and determinants (MONITOR-GCSF study). Future Oncology 2019;15:897-907.

A co-curricular diabetes-specific elective with interprofessional students and faculty. Curr Pharm Teach Learn. 2019;11(2):172-177. DOI:10.1016/j.cptl.2018.11.006.

From Big Data to Precision Medicine. Front Med 2019 6:34.

Genetic determinants of risk in pulmonary arterial hypertension: international case-control studies and meta-analysis. Lancet Respir Med 2019; 7(3):227-238.

Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know? Pharmacogenomics. 2018; 19(18): 1413-1422

Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Annu Rev Pharmacol Toxicol. 2019; 59: 463-486.

Interprofessional Integrative Healthcare Education: What Do Primary Care Educational Programs Need? J Interprofes Educ & Pract. 2019;14:6-12.

Use of Machine Learning to Predict Risk of Opioid Overdose among Medicare Beneficiaries Prescribed Opioids. JAMA Network Open 2019; 2(3): e190968.doi:10.1001/jamanetworkopen. 2019. 0968.


Presentations

Jason H. Karnes, PharmD, PhD, BCPS, FAHA

  • “Predicting Immune-Mediated Adverse Drug Reactions and Emerging Immunogenetic Discoveries” as part of a session, “Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions." American Society for Clinical Pharmacology and Therapeutics. 2019 March 13-16; Washington DC.
  • “Challenges and Solutions for Precision Medicine in Diverse Patient Populations.” University of Florida Precision Medicine Conference, Orlando, FL. 2019 March.

Hanna Phan, PharmD, FCCP, FPPAG

  • “Myths and Truths of Medication Use in Children.” American Pharmacists Association (APhA) Annual Meeting. Seattle, WA. March 2019.


Poster Presentations

Psychotropic Medication Use Patterns in Home-Based Primary Care: a Systematic Review. American Association for Geriatric Psychiatry Annual Meeting, Atlanta, GA; March 2019.

Use of Melatonin Receptor Agonists for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis. 2019 University of Arizona Student Showcase Research Forum, Tucson, AZ; February 2019. (Received Katheryne B.Willock Library Research Award ($1000) and First Place in Best Human Health Research Award ($750).)


Kudos

Nancy Alvarez, PharmD, BCPS

  • Completed service on the American Pharmacists Association — two terms as a trustee and a term as a presidential officer — 162nd President of APhA 2017-2018.

Jason H. Karnes, PharmD, PhD, BCPS, FAHA

  • Received NIH Grant, 5 years, $769,025, Genomic and Transcriptomic Influences on Heparin-Induced Thrombocytopenia.

Michael Katz, PharmD

  • Appointed to the Accreditation Council for Pharmacy Education International Commission.

Hanna Phan, PharmD, FCCP, FPPAG

  • Received a grant w with Seto D, Romero-Aleshire J, Eastep TG, Bowen A, Sharpe A, Hall-Lipsy E, AHEC, Medication Education in Cystic Fibrosis (CF) Care Centers: Perspectives of Persons with CF, Caregivers of Infants/Children/Adolescents with CF, and CF Healthcare Providers
  • Received a grant with Lam M, Bradshaw S, Anderson K, Bowen A, Sharpe A, Jackson K, Hall-Lipsy E, Anderson K, AHEC, Complementary Alternative Medicine (CAM), Cannabis, and Therapeutic Diets in Cystic Fibrosis (CF): Perspectives of Persons with CF, Caregivers of Infants/Children/Adolescents with CF, and CF Healthcare Providers